Clinical Scorecard: Trends Over Time in Neuro-Oncology Publications: A Bibliometric Analysis of a Key Journal in the Discipline

At a Glance

Key Highlights

• CNS tumors remain a significant global health burden with incidence rates of 2.1 to 5.8 per 100,000 annually and are leading causes of death in children and adults.
• The Journal of Neuro-Oncology (JNO) serves as a pivotal platform for disseminating research, clinical trials, and reviews in neuro-oncology since 1983.
• Bibliometric analysis reveals increasing publication trends worldwide with disparities based on country and gender; a novel country-based representativeness and diversity (CRD) index was developed to assess fair representation.

Guideline-Based Recommendations

Diagnosis

• Utilize advanced molecular profiling and neuroimaging techniques to improve CNS tumor characterization.

Management

• Incorporate multidisciplinary research findings from journals like JNO to inform therapeutic strategies.

Monitoring & Follow-up

• Track publication trends and research outputs to identify emerging areas and disparities in neuro-oncology research.

Risks

• Be aware of potential publication biases related to country of origin and gender disparities in academic research.

Patient & Prescribing Data

Patients with CNS tumors receiving neuro-oncology care

Research advancements disseminated through JNO inform evolving therapeutic approaches, though specific prescribing data are not detailed in this bibliometric study.

Clinical Best Practices

• Promote equitable global research collaboration to reduce disparities in neuro-oncology literature and clinical knowledge.
• Support gender diversity and inclusion in neuro-oncology research authorship and leadership.
• Leverage bibliometric analyses to guide journal editorial policies and research funding priorities.

References

• Global incidence and mortality of CNS tumors
• Bibliometric methods in medical research
• Gender disparities in medical research authorship